Aliso Viejo, CA, United States of America

Tugan Muftuler

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tugan Muftuler: Innovator in Therapeutic Angiogenesis

Introduction

Tugan Muftuler is a prominent inventor based in Aliso Viejo, CA (US). He has made significant contributions to the field of therapeutic angiogenesis, particularly in the treatment of spinal and other tissue pathologies. With a total of 4 patents, his work focuses on innovative methods for diagnosing and treating ischemic conditions.

Latest Patents

One of Tugan Muftuler's latest patents is titled "Therapeutic angiogenesis for treatment of the spine and other tissues." This invention outlines methods for diagnosing and treating ischemic spinal conditions, degenerative disc disease, back pain, and other tissue pathologies. It emphasizes the categorization of patients with ischemic spine disease into subsets that may respond positively to therapy. The patent discloses therapies that stimulate neovascularization to enhance perfusion in spinal and other anatomies.

Another significant patent is "Systems and methods for angiogenic treatment in wound healing." This invention relates to diagnosing, ameliorating, and treating ischemic tissues in patients suffering from diminished microvascular blood flow. It categorizes patients with ischemic tissue conditions into specific subsets that may respond to therapy. The invention includes various therapies that stimulate angiogenesis, vasculogenesis, arteriogenesis, and neovascularization to improve tissue perfusion.

Career Highlights

Throughout his career, Tugan Muftuler has worked with notable companies, including Cardiovascular Biotherapeutics, Inc. His innovative approaches have positioned him as a key figure in the field of therapeutic interventions.

Collaborations

Tugan has collaborated with esteemed professionals such as Thomas J Stegmann and Kenneth A Thomas. Their combined expertise has contributed to advancements in therapeutic angiogenesis and related fields.

Conclusion

Tugan Muftuler's work in therapeutic angiogenesis showcases his dedication to improving patient outcomes through innovative treatments. His patents reflect a commitment to addressing complex medical challenges, particularly in ischemic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…